Allergan Generic Drug Pricing Securities Litigation

By providing your information, either on paper, electronically or through a website, you consent to us storing and using your information for case administration purposes only. Our site uses tracking technologies to tailor your experience and understand how you and other visitors use our site. By continuing to navigate this site you consent to use of these tracking technologies. For more information on how we use your personal data, please read our Privacy Policy.

Allergan Generic Drug Pricing Securities Litigation
Home
Home
Notice
Notice
Claim Form
Claim Form
File Online Claim Form
File Online Claim Form
Court Documents
Court Documents
Institutional Electronic Filing
Institutional Electronic Filing
How to Report a Change of Address
How to Report a Change of Address
How to Report a Change of Name
How to Report a Change of Name
Lead Counsel
Lead Counsel
Contact Us
Contact Us


The information contained on this web page is only a summary of the information presented in more detail in the Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Settlement Hearing; and (III) Motion for an Award of Attorneys’ Fees and Litigation Expenses (the “Notice”), which you can access by clicking here.  Since this web page is just a summary, you should review the Notice for additional details.

The Parties have reached a settlement of this action for $130,000,000 in cash (the “Settlement”) for the benefit of the Settlement Class (defined below). On November 17, 2021, the Court held a hearing on final approval of the Settlement and related matters and announced that it would approve the Settlement. On November 22, 2021, the Court entered a Judgment finally approving the Settlement and orders approving the proposed Plan of Allocation for the proceeds of the Settlement and awarding attorney's fees and litigation expenses to Plaintiffs’ Counsel.

If you are a member of the Settlement Class, you are subject to the Settlement and you may be eligible for a payment from the Settlement. The Settlement Class consists of the following three subclasses: 

(1) as to claims arising under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act"), all persons and entities who purchased or otherwise acquired Allergan plc (before June 15, 2015, known as Actavis plc) common and/or preferred stock between October 29, 2013 and November 2, 2016, both dates inclusive, and were damaged thereby;

(2) as to claims arising under Section 14(a) of the Exchange Act in connection with the merger between Actavis plc and Forest Laboratories, Inc. (i.e., Forest Merger), all persons and entities who held Forest common stock as of May 2, 2014, and were entitled to vote on the Forest Merger, and acquired shares of Allergan common stock in the Forest Merger and were damaged thereby; and

(3) as to claims arising under Section 14(a) of the Exchange Act in connection with the merger between Actavis plc and Allergan, Inc. (i.e., Actavis Merger), all persons and entities who held Allergan, Inc. common stock as of January 22, 2015, and were entitled to vote on the Actavis Merger, and acquired shares of Allergan common stock in the Actavis Merger and were damaged thereby.            

Excluded from the Settlement Class are certain persons and entities who are excluded by definition (see paragraph 29 of the Notice) or who requested exclusion from the Settlement Class.

If you are a member of the Settlement Class, in order to be potentially eligible for a payment from the Settlement, you must submit a Claim Form postmarked (if mailed) or online (using this website), together with adequate supporting documentation, no later than December 27, 2021.

Payments to eligible claimants will be made only after any appeals are resolved, and after the completion of all claims processing. Please be patient, as this process will take some time to complete.


If you have questions, you may call the Allergen Securities Litigation Help Line at  1-877-777-9328 or email info@AllerganDrugPricingSecuritiesLitigation.com.    


IMPORTANT DEADLINE

DECEMBER 27, 2021

Claim Filing Deadline


 
adobe reader imageYou will need Adobe Reader to view documents on this site. You can learn more about Adobe Reader and download the latest version by clicking here.